These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2908215)

  • 21. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.
    Bertherat J; Timsit J; Bluet-Pajot MT; Mercadier JJ; Gourdji D; Kordon C; Epelbaum J
    J Clin Invest; 1993 Apr; 91(4):1783-91. PubMed ID: 8097209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Basic and clinical investigations on pituitary gland].
    Irie M
    Nihon Naika Gakkai Zasshi; 1989 Aug; 78(8):1130-9. PubMed ID: 2572656
    [No Abstract]   [Full Text] [Related]  

  • 23. Endocrine responses to anaesthetic agents.
    Oyama T
    Br J Anaesth; 1973 Mar; 45(3):276-81. PubMed ID: 4349270
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification and purification of factor A-GHRH from hypothalami which releases growth hormone.
    Currie BL; Johansson KN; Greibrokk T; Folkers K; Bowers CY
    Biochem Biophys Res Commun; 1974 Sep; 60(2):605-9. PubMed ID: 4609207
    [No Abstract]   [Full Text] [Related]  

  • 25. Diverse effects of glucocorticoids on the hypothalamic pituitary axis in rat growth hormone secretion.
    Ohyama T; Sato M; Wada Y; Takahara J
    Endocr J; 1996 Oct; 43 Suppl():S115-7. PubMed ID: 9076357
    [No Abstract]   [Full Text] [Related]  

  • 26. Pituitary growth hormone and hypothalamic somatostatin in young female rats versus old constant estrous female rats.
    Forman LJ; Sonntag WE; Hylka VW; Meites J
    Experientia; 1985 May; 41(5):653-4. PubMed ID: 2860005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of growth hormone-releasing activity of (pyro)Glu-Ser-Gly-NH2.
    Schally AV; Redding TW; Takahara J; Coy DH; Arimura A
    Biochem Biophys Res Commun; 1973 Dec; 55(3):556-62. PubMed ID: 4586612
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of synthetic growth hormone-releasing inhibiting factor on the secretion of growth hormone and prolactin in rats.
    Sawano S; Baba Y; Kokubu T; Ishizuka Y
    Endocrinol Jpn; 1974 Oct; 21(5):399-405. PubMed ID: 4614970
    [No Abstract]   [Full Text] [Related]  

  • 29. Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats.
    Wehrenberg WB; Ling N; Brazeau P; Esch F; Böhlen P; Baird A; Ying S; Guillemin R
    Biochem Biophys Res Commun; 1982 Nov; 109(2):382-7. PubMed ID: 6817757
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypothalamic somatostatin-14 and -28 biosynthesis: effects of anesthetics and hypophysectomy.
    Van Itallie CM; Fernstrom JD
    Brain Res; 1982 Oct; 249(1):177-83. PubMed ID: 6128056
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth hormone-releasing factor: chemistry and physiology.
    Guillemin R; Zeytin F; Ling N; Böhlen P; Esch F; Brazeau P; Bloch B; Wehrenberg WB
    Proc Soc Exp Biol Med; 1984 Apr; 175(4):407-13. PubMed ID: 6424128
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of anesthetics on the basal secretion of immunoreactive growth hormone in rats].
    Bluet-Pajot MT; Schaub C
    C R Acad Hebd Seances Acad Sci D; 1978 Jun; 286(23):1707-10. PubMed ID: 100239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vivo assay of antisomatotropic activity of somatostatin and two of its analogs].
    Franchimont P; Ghys A; Brison J; Haze-Hagelstein MT; Detournay JM; Dremier C; Scarso A; Demoulin A; Dirkx J
    C R Seances Soc Biol Fil; 1977; 171(3):673-8. PubMed ID: 144010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone.
    Borgeat P; Labrie F; Drouin J; Bélanger A; Immer H; Sestanj K; Nelson V; Götz M; Schally AV; Coy DH; Coy EJ
    Biochem Biophys Res Commun; 1974 Feb; 56(4):1052-9. PubMed ID: 4363638
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro effects of synthetic somatotropin-release inhibiting factor on cyclic AMP level and GH release in rat anterior pituitary gland.
    Kaneko T; Oka H; Saito S; Munemura M; Musa K; Oda T
    Endocrinol Jpn; 1973 Oct; 20(5):535-8. PubMed ID: 4365523
    [No Abstract]   [Full Text] [Related]  

  • 36. Somatostatin inhibition of rat growth hormone release in vitro in the presence of BaCl2 or 3-isobutyl-1-methylxanthine.
    Schofield JG; Mira-Moser F; Schorderet M; Orci L
    FEBS Lett; 1974 Sep; 46(1):171-4. PubMed ID: 4371679
    [No Abstract]   [Full Text] [Related]  

  • 37. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites.
    Codd EE; Shu AY; Walker RF
    Neuropharmacology; 1989 Oct; 28(10):1139-44. PubMed ID: 2812284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin and growth hormone releasing factor: synthesis, location, metabolism and function.
    Gómez-Pan A; Rodriguez-Arnao MD
    Clin Endocrinol Metab; 1983 Nov; 12(3):469-507. PubMed ID: 6142777
    [No Abstract]   [Full Text] [Related]  

  • 39. Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo.
    Wehrenberg WB; Baird A; Ling N
    Science; 1983 Aug; 221(4610):556-8. PubMed ID: 6408735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion.
    Brazeau P; Vale W; Rivier J; Guillemin R
    Biochem Biophys Res Commun; 1974 Oct; 60(4):1202-7. PubMed ID: 4607622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.